Hartford Investment Management Co. trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 6.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 94,670 shares of the healthcare conglomerate’s stock after selling 6,584 shares during the quarter. UnitedHealth Group comprises 1.3% of Hartford Investment Management Co.’s holdings, making the stock its 10th largest position. Hartford Investment Management Co.’s holdings in UnitedHealth Group were worth $48,279,000 at the end of the most recent quarter.
Other large investors have also recently made changes to their positions in the company. NorthCrest Asset Management LLC raised its stake in shares of UnitedHealth Group by 9.5% in the first quarter. NorthCrest Asset Management LLC now owns 518 shares of the healthcare conglomerate’s stock worth $264,000 after purchasing an additional 45 shares during the last quarter. Domani Wealth LLC grew its holdings in UnitedHealth Group by 0.7% during the first quarter. Domani Wealth LLC now owns 3,542 shares of the healthcare conglomerate’s stock worth $1,806,000 after acquiring an additional 25 shares during the period. Lincoln National Corp grew its holdings in UnitedHealth Group by 15.1% during the fourth quarter. Lincoln National Corp now owns 8,951 shares of the healthcare conglomerate’s stock worth $4,495,000 after acquiring an additional 1,174 shares during the period. Salvus Wealth Management LLC grew its holdings in UnitedHealth Group by 23.5% during the first quarter. Salvus Wealth Management LLC now owns 782 shares of the healthcare conglomerate’s stock worth $399,000 after acquiring an additional 149 shares during the period. Finally, YorkBridge Wealth Partners LLC grew its holdings in UnitedHealth Group by 1.8% during the fourth quarter. YorkBridge Wealth Partners LLC now owns 15,296 shares of the healthcare conglomerate’s stock worth $7,681,000 after acquiring an additional 272 shares during the period. Hedge funds and other institutional investors own 87.48% of the company’s stock.
Several research firms recently commented on UNH. Cowen raised their target price on UnitedHealth Group from $512.00 to $596.00 in a report on Monday, April 18th. Loop Capital began coverage on UnitedHealth Group in a report on Thursday, June 16th. They issued a “buy” rating and a $575.00 price objective on the stock. Royal Bank of Canada set a $563.00 price objective on UnitedHealth Group and gave the company an “outperform” rating in a report on Monday, April 18th. Sanford C. Bernstein lowered UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 price objective on the stock. in a report on Thursday, May 26th. They noted that the move was a valuation call. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on UnitedHealth Group from $482.00 to $549.00 and gave the stock a “buy” rating in a research note on Monday, April 18th. Three investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $555.73.
In related news, Director Richard T. Burke sold 2,500 shares of the business’s stock in a transaction on Thursday, May 19th. The stock was sold at an average price of $478.96, for a total transaction of $1,197,400.00. Following the completion of the transaction, the director now directly owns 1,215,000 shares of the company’s stock, valued at approximately $581,936,400. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,273 shares of the business’s stock in a transaction on Thursday, June 23rd. The stock was sold at an average price of $499.00, for a total value of $635,227.00. Following the transaction, the executive vice president now directly owns 8,104 shares of the company’s stock, valued at $4,043,896. The disclosure for this sale can be found here. Insiders sold a total of 6,273 shares of company stock worth $3,065,752 in the last quarter. Company insiders own 0.40% of the company’s stock.
NYSE:UNH opened at $513.63 on Friday. UnitedHealth Group Incorporated has a 52 week low of $383.12 and a 52 week high of $553.29. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.54. The company has a market capitalization of $481.87 billion, a P/E ratio of 28.11, a P/E/G ratio of 1.54 and a beta of 0.83. The stock’s fifty day moving average is $492.84 and its two hundred day moving average is $492.36.
UnitedHealth Group (NYSE:UNH – Get Rating) last posted its earnings results on Thursday, April 14th. The healthcare conglomerate reported $5.49 EPS for the quarter, beating analysts’ consensus estimates of $5.40 by $0.09. The company had revenue of $80.15 billion for the quarter, compared to the consensus estimate of $78.77 billion. UnitedHealth Group had a return on equity of 24.74% and a net margin of 5.86%. The company’s revenue for the quarter was up 14.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.31 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 21.75 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 28th. Investors of record on Monday, June 20th were issued a $1.65 dividend. This represents a $6.60 annualized dividend and a dividend yield of 1.28%. The ex-dividend date of this dividend was Thursday, June 16th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.45. UnitedHealth Group’s payout ratio is currently 36.12%.
UnitedHealth Group Company Profile: (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments. UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.
Further Reading:
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Get Rating).
Receive News & Ratings for UnitedHealth Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.
.